glp 1 agonist for prediabetes GLP1 Receptor Agonists—Effects beyond Obesity and Diabetes GLP-1 for Diabetes vs GLP-1

The difference is one of scale and specificity, not of kind

These pathways regulate various aspects of neuronal health, such as neuroplasticity, apoptosis, mitochondrial function, and inflammation, underscoring the potential of GLP-1 in treating cognitive disorders (Figure 2)

Here we show that GLP-1 RAs are associated with lower risks of mortality, major cardiovascular events (MACEs), and major adverse kidney events (MAKEs) in type 2 diabetes patients with acute kidney disease (AKD)

Eggers test was used to assess publication bias

J Natl Cancer Inst 117: 476485, 2025

Drugs including semaglutide (Ozempic and Wegovy), tirzepatide (Zepbound and Mounjaro) and liraglutide (Saxenda and Victoza) are proven to support weight loss, glucose control and other health concerns